8Miller BE,Shem DF, Arheart K, et al. The presentation of adenocarcinoma of the uterine cerviex [ J ]. Cancer, 1993, 73 (4) :1281.
9Yamamoto R, Okamoto K, Yukiharu T,et al. A study of risk factors for ovarian metastases in stage Ⅰ b-Ⅲ b cervical carcinoma and analysis of ovarian function after a transposition [ J ]. Gynecol Oncol,2001,82 :312 - 316.
5WONG R K W, FYLES A, MILOSEV M. Hetero - geneity of polargraphic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor varcability, probeposition and trace depth[J ]. lnt J Radiat Oncol Biol Phys, 1997,39:405 -412.
6STUBEN G,STUSCHKE M,KNUHMANN K,et al. The effect of combined nicetinamide and carbongen treatments in human tunxour xenografts: oxygenation and turaour control studies[J ].Radiother Oncol, 1998,48:143 - 148.
7HENKE M, GUTTENBERGER R, Erythropoietin in radiation oncology - A review[ J ]. Ontology, 2000,58 (2) : 175 - 182.
8GROGAN IM, THOMAS G M, MELAMED I, et al. The importmace of hemoglobin levels durging radiotherapy for carcinoma of the cervix[J ]. Cancer, 1999,86(8) : 1 528 - 1 536.
9DEMETRI G D, KRIS M, WADE J, et al. Quality of life benefit in chemotherapy patients treated with epoietin alpha is independent of disease respose of tumor type: results from a propective community oncology study[ J ]. J Clin Oncol, 1998,16 ( 10 ) : 3 412- 3 425.
